SAN FRANCISCO—Patients with inflammatory bowel disease face an array of challenges in maintaining adherence to therapy, particularly with respect to insurance coverage, which often frustrates treat-to-target goals, according to two new studies presented at the 2025 Crohn’s and Colitis Congress that attempted to quantify adherence and barriers to care.
Insurance issues are at the forefront of these challenges, according to Ariel Jordan, MD, who presented a study examining healthcare